Harvard Bioscience HBIO
NASDAQ HBIO
$8.45 -0.04 (-0.47%)
At close: Oct 22, 2026 · 4:00 PM EDT

Harvard Bioscience (HBIO) Liabilities from Discontinued Operations (2017)

Updated

Harvard Bioscience's Liabilities from Discontinued Operations came in at $1.31 million for Q4 2017.

Analysis

Harvard Bioscience (HBIO) Liabilities from Discontinued Operations (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn
10 Harvard Bioscience 38.47 Mn 9.43 Mn 12.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1.31 Mn
API Access

Harvard Bioscience Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=HBIO&period=max&api_key=YOUR_API_KEY